Comparative study of magnetic properties and the anticancer effect of superparamagnetic and ferromagnetic iron oxide nanoparticles in the nanocomplex with doxorubicin
DOI:
https://doi.org/10.15407/dopovidi2015.09.113Keywords:
carcinosarcoma Walker-256, electromagnetic field, electron spin resonance, ferromagnetic nanoparticles, magnetic properties, superparamagnetic nanoparticlesAbstract
Mechano-magneto-chemically synthesized magnetic nanocomplex (MNC) of superparamagnetic iron oxide Fe3O4 nanoparticles (NP) and anticancer drug doxorubicin (DR) had significantly lower saturation magnetic moment and magnetic hysteresis loop area as compared to the MNC of ferromagnetic NP. However, the last was characterized by lower coercivity. MNC of superparamagnetic NP and DR had g-factors of 2.00, 2.30, and 4.00. MNC of ferromagnetic NP and DR had the g-factor of 2.50, and the integrated intensity of electron spin resonance signals was by 61% greater. Superparamagnetic iron oxide Fe3O4 NP in MNC with DR initiated a greater antitumor effect during magnetic nanotherapy of animals with carcinosarcoma Walker-256 as compared to the MNC composed of ferromagnetic NP and DR. In the future, superparamagnetic iron oxide Fe3O4 NP as a part of the nanocomplex with DR can be used in theranostics – a methodology that combines magnetic resonance diagnostics and magnetic nanotherapy using MNC both as therapeutic and diagnostic agents.
Downloads
References
Jemal A., Bray F., Ferlay J. et al. CA Cancer J. Clin., 2011, 61, Iss. 2: 69–90. https://doi.org/10.3322/caac.20107
Yoo D., Lee J.H., Shin T.H. et al. Acc. Chem. Res., 2011, 44, Iss. 10: 863–874. https://doi.org/10.1021/ar200085c
Rosensweig R.E. J. Magn. Magn. Mat., 2002, 252: 370–374. https://doi.org/10.1016/S0304-8853(02)00706-0
Peiris P.M., Toy R., Doolittle E. et al. ACS Nano, 2012, 6, Iss. 10: 8783–8795. https://doi.org/10.1021/nn303833p
Mornet S., Vasseur S., Grasset F. et al. J. Mater. Chem., 2004, 14: 2161–2175. https://doi.org/10.1039/b402025a
Maier-Hauff K., Ulrich F., Nestler D. et al. J. Neurooncol., 2011, 103, Iss. 2: 317–324. https://doi.org/10.1007/s11060-010-0389-0
Hergt R., Dutz S. J. Magn. Magn. Mat., 2007, 311: 187–192. https://doi.org/10.1016/j.jmmm.2006.10.1156
Orel V., Shevchenko A., Romanov A. et al. Nanomedicine, 2015, 11, Iss. 1: 47–55.
Orel V.E., Shevchenko A.D., Rykhalskiy A.Y. et al. Investigation of nonlinear magnetic properties magnetomechano-chemically synthesized nanocomplex from magnetite and antitumor antibiotic doxorubicin, Nanocomposites, Nanophotonics, Nanobiotechnology, and Applications Springer Proceedings in Physics, Vol. 156, Cham: Springer Intern. Publ., 2015: 103–110.
Giuliani F.C., Kaplan N.O. Cancer Res., 1980, 40: 4682–4687.
Emanuel N.M. Kinetics of experimental tumor processes, Moscow: Nauka, 1977 (in Russian).
Petrović A.P., Paré A., Paudel T.R. et al. New J. Phys., 2014, 16, 103012, doi: 088/1367-2630/16/10/103012.
Golovin Y.I., Gribanovskiy S.L., Golovin D.Y. et al. Physica tverdogo tela, 2014, 56, Iss. 7: 1292–1300 (in Russian).
Burlaka A.P., Sidorik E.P. Redox-dependent signaling molecules in the mechanisms of tumor processes, Kyiv: Nauk. Dumka, 2014 (in Russian).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Reports of the National Academy of Sciences of Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
